Vera Therapeutics (VERA) Debt Ratio (2021 - 2026)
Vera Therapeutics' (VERA) quarterly Debt Ratio came in at 0.12 in Q1 2026, up 47.27% YoY from 0.08 in Q1 2025, and up 18.48% on a QoQ basis from 0.1 in Q4 2025.
Vera Therapeutics (VERA) Debt Ratio (2021 - 2026) Analysis & Trends
Vera Therapeutics (VERA) has 6 years of Debt Ratio data on file, last reported at 0.12 in Q1 2026.
- Quarterly Debt Ratio rose 47.27% year-over-year to 0.12 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.12 (up 47.27% YoY) and the FY2025 annual result came in at 0.1, up 33.57% from the prior year.
- Debt Ratio improved to 0.12 in Q1 2026, from 0.1 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 0.28 in Q4 2023 to a low of 0.04 in Q1 2022.
- A 5-year average of 0.12 and a median of 0.13 in 2024 frame the typical range for Debt Ratio.
- Annual changes were most pronounced in 2022 — Debt Ratio surged 316.8% — and 2024, when it sank 73.16%.
- Tracing VERA's Debt Ratio over 5 years: stood at 0.21 in 2022, then soared by 34.43% to 0.28 in 2023, then slumped by 73.16% to 0.08 in 2024, then jumped by 33.57% to 0.1 in 2025, then advanced by 18.48% to 0.12 in 2026.
- The last three Debt Ratio figures came in at 0.12 (Q1 2026), 0.1 (Q4 2025), and 0.14 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.12 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.47 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.26 |
| 10 | Vera Therapeutics | 2.28 Bn | 2.28 Bn | - | 0.14 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.14 |
| Mar 31, 2026 | 0.12 |
| Dec 31, 2025 | 0.10 |
| Sep 30, 2025 | 0.14 |
| Jun 30, 2025 | 0.13 |
| Mar 31, 2025 | 0.08 |
| Dec 31, 2024 | 0.08 |
| Sep 30, 2024 | 0.14 |
| Jun 30, 2024 | 0.13 |
| Mar 31, 2024 | 0.12 |
| Dec 31, 2023 | 0.28 |
| Sep 30, 2023 | 0.14 |
| Jun 30, 2023 | 0.13 |
| Mar 31, 2023 | 0.13 |
| Dec 31, 2022 | 0.21 |
| Sep 30, 2022 | 0.05 |
| Jun 30, 2022 | 0.05 |
| Mar 31, 2022 | 0.04 |
| Dec 31, 2021 | 0.07 |
| Sep 30, 2021 | 0.01 |